Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers

21Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Objective: Advanced biliary tree cancers are often diagnosed at an advanced or metastatic stage and have poor prognoses. We reported the promising anti-tumor activity of gemcitabine/5-fluorouracil (5-FU)/cisplatin (CDDP) therapy, called 'GFP chemotherapy' in a pilot study. Methods: Twenty-one patients with advanced or metastatic biliary tree cancers with no prior chemotherapy were enrolled in this Phase II trial. Patients were treated on 4-week cycle GFP chemotherapy consisting of gemcitabine at 1000 mg/m. 2 on days 1, 8 and 15, and 5-FU at 150 mg/m. 2 and CDDP at 3 mg/m. 2 on days 1-5, 8-12 and 15-19. After two cycles, a 4-week outpatient treatment of gemcitabine (1000 mg/m. 2) on days 1 and 15 combined with 5-FU (500 mg/m. 2) and CDDP (7 mg/m. 2) on days 1 and 15 was commenced. Treatment was repeated until tumor progression or remission allowing curative operation, or unacceptable toxicity occurred. Results: Of these 21 patients, no complete responses were observed, but 7 patients (33.3%) demonstrated partial responses (PRs) with an additional 12 patients (57.2%) having stable diseases, as assessed by RECIST. Three patients with PRs were treated by curative operation after GFP chemotherapy, and all of them survived with no recurrence for over 3 years. The median overall survival time was 18.8 months, and median time to progression was 13.4 months. Grade 3 side effects such as leukopenia, thrombocytopenia and anemia were found in six patients (28.6%), but no patients dropped out because of toxicity. Conclusions: This GFP chemotherapy has promising anti-tumor activity and is well tolerated in patients with advanced biliary tree cancers. © The Authors (2009). Published by Oxford University Press.

References Powered by Scopus

Medical progress: Biliary tract cancers

906Citations
N/AReaders
Get full text

Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials

430Citations
N/AReaders
Get full text

Worldwide trends in mortality from biliary tract malignancies

428Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cholangiocarcinoma

103Citations
N/AReaders
Get full text

The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics

84Citations
N/AReaders
Get full text

Precision medicine in cholangiocarcinoma

59Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Yamashita, Y. ichi, Taketomi, A., Itoh, S., Harimoto, N., Tsujita, E., Sugimachi, K., … Maehara, Y. (2009). Phase II trial of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) chemotherapy in patients with advanced biliary tree cancers. Japanese Journal of Clinical Oncology, 40(1), 24–28. https://doi.org/10.1093/jjco/hyp119

Readers' Seniority

Tooltip

Professor / Associate Prof. 3

38%

PhD / Post grad / Masters / Doc 3

38%

Researcher 2

25%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

78%

Agricultural and Biological Sciences 1

11%

Social Sciences 1

11%

Save time finding and organizing research with Mendeley

Sign up for free